Clover Health Investments Corp. (NASDAQ: CLOV) saw its stock price jump on Thursday, October 9, 2026, following a positive rating announcement from the Centers for Medicare & Medicaid Services (CMS).
The stock opened at $5.16 and reached a high of $5.21 during the session, with a day range of $4.64 to $5.21. The company’s market capitalization is reported at $2.58 billion.
The price movement was driven by the CMS awarding Clover Health’s Medicare Advantage plans high ratings for the 2027 plan year. The company is a healthcare technology firm that focuses on empowering Medicare physicians to manage chronic diseases through its software platform, Clover Assistant.
Clover Health’s stock is currently trading at $4.86, representing a gain of 6.11% for the day. The stock has a 52-week range of $1.58 to $5.59.
